Aiming for a stable TSH level (e.g., between 0.53.0 mIU/L) before starting GLP-1 therapy is often recommended
Type 2 diabetes in adults: management (NG28) Rationale and impact
Inside the Doctor-Led GLP-1 Program Revolutionizing Modern Weight Management In an era where effective weight loss solutions often come with overwhelming costs or limited access, MEDVi has emerged as a transformative force in the GLP-1 space
PlexusDx serves patients with a BMI of 27 or higher who have weight-related conditions, or a BMI of 30 or above without additional health concerns
This is especially important if youre participating in high-intensity exercises or prolonged workout sessions
Nausea is the most common side-effect GLP-1 symptom, followed by vomiting, sour burps, heartburn and gastroparesis Side-Effect Profile of GLP-1s, from Worst to Best (% reflects estimated number of patients with GI side-effects) 50% Semaglutide (Ozempic, Rybelsus, Wegovy) 40% Tirzepatide (Saxenda, Mounjaro) 40% Liraglutide (Victoza, Saxenda) 30% Lixisenatide (Adlyxin USA, Lyxumia UK) 10% Dulaglutide (Trulicity) 10% Exenatide (Byetta, Bydureon) Wegovy, Mounjaro, and Saxenda FDA-approved for weight loss
